New CAF-Acceleron Scholarships for Academic Achievements Accepting Applications from U.S. Thalassemia Community
March 31, 2021 – The Cooley’s Anemia Foundation and Acceleron Pharma Inc. are offering up to four college scholarships of $5,000 each to individuals with a clinically significant form of thalassemia (alpha or beta thalassemia major, beta thalassemia intermedia, e beta thalassemia, hemoglobin H disease or hemoglobin H disease Constant Spring). Two of these scholarships are for thalassemia patients who are currently enrolled in a college program and will continue to be enrolled in a college program in the upcoming fall semester and two are for high school seniors who will be starting a college program in the fall. These awards are for residents of the United States.
These awards are merit based and will place significant emphasis on the applicant’s academic record and the quality of the essay submitted as part of the individual’s application package. Other factors that will be considered include the strength of the letters of recommendations received, as well as the individual’s involvement in the thalassemia community.
Applicants must complete the full application form and package (which includes more information and details) and submit to the Cooley’s Anemia Foundation no later than May 15, 2021. Incomplete or late applications will not be accepted. The application package for high school seniors may be accessed by clicking here; the application package for current college students may be accessed by clicking here.
Applications will be reviewed by our Scholarship Review Committee. Awardees will be selected and notified by June 15, 2021. Those who are not selected for an award will also be contacted.
Scholarship funds are intended for tuition or room and board expenses and will be forwarded directly to the college rather than to the awardee.
The Cooley’s Anemia Foundation thanks Acceleron Pharma Inc. for its generous support of this important program.
For more information, please contact firstname.lastname@example.org.